This activation is induced and maintained by overexpressed ZEB1 recruiting the transcriptional coactivators p300/PCAF to the ATM promoter, which results in the chemoresistance of breast cancer cells (Zhang et al., 2018). Here, ATM is linked to breast carcinoma.